New drug delivery technologies, such as nanoparticles, hydrogels, and self-powered microgrippers, are showing great potential ...

Approximately three million Americans have inflammatory bowel disease (IBD). IBD is an umbrella term for Crohn’s disease and ...

Explore the promising results of haematopoietic stem cell transplantation as a treatment for early-onset inflammatory bowel ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Black Americans with inflammatory bowel diseases are more likely ... trial to help researchers learn more about IBD disease processes, symptoms, and treatment response in people of color.

New Inflammatory Bowel Disease Testing Protocol Could Speed Up Diagnosis Apr. 16, 2024 — Patients with suspected inflammatory bowel disease (IBD ... clinical trial of treatment strategies ...

Take Steps is the Crohn’s & Colitis Foundation’s signature fundraising event. This year (2025), the event will take place at ...

Using vedolizumab first, before tumor necrosis factor-α inhibitors, improved quality-adjusted life-years in both ulcerative ...

People with inflammatory bowel disease (IBD) also report more panic and anxiety. The threat of flare-ups can keep people worried and on guard and make gut symptoms worse.

The use of 5-aminosalicylic acid with ustekinumab shows no significant overall benefits in inflammatory bowel disease. However, post hoc subgroup analyses suggest potential benefits in specific ...

Kiji Therapeutics Engineered MSCs + IL-10 and CXCR4 offer tighter targeting and greater potency for challenging inflammatory diseases.

Although the appendix is generally believed to be a vestigial organ, there is growing evidence pointing to its possible role in modulating gut immunity and microbial homoeostasis.1,2 These roles have ...